Literature DB >> 15830476

Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin.

E H Nauta, H Mattie, W R Goslings.   

Abstract

According to Gibaldi et al. (1968, 1970), the higher serum concentrations of penicillins and cephaloridine reached after administration of probenecid are due not only to slower renal elimination but also to an altered distribution in the body. To determine whether probenecid has a direct effect on the distribution of cloxacillin, the elimination and distribution of cloxacillin was studied in six patients, five lacking kidney function and one with a partially impaired renal function, in the presence or absence of probenecid. No significant difference was found between the mean values of the volume of distribution of cloxacillin with and without probenecid (13.0 and 12.6 liters, respectively). Thus, the hypothesis of Gibaldi et al. could not be confirmed for cloxacillin in patients lacking kidney function. In spite of the absence of kidney function, the value of the elimination rate constant was significantly decreased in the presence of probenecid (from 0.326 to 0.263/h). This might be explained by a blockade by probenecid of the elimination of cloxacillin by the liver.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15830476      PMCID: PMC444640          DOI: 10.1128/AAC.6.3.300

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

2.  The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material.

Authors:  P G DAYTON; T F YU; W CHEN; L BERGER; L A WEST; A B GUTMAN
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

3.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

4.  Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects.

Authors:  E H Nauta; H Mattie; W R Goslings
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

5.  Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications.

Authors:  S Kenwright; A J Levi
Journal:  Lancet       Date:  1973-12-22       Impact factor: 79.321

6.  Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice.

Authors:  H Mattie; W R Goslings; E L Noach
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

7.  Modification of penicillin distribution and elimination by probenecid.

Authors:  M Gibaldi; D Davidson; M E Plaut; M A Schwartz
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-05

8.  Apparent effect of probenecid on the distribution of penicillins in man.

Authors:  M Gibaldi; M A Schwartz
Journal:  Clin Pharmacol Ther       Date:  1968 May-Jun       Impact factor: 6.875

9.  Blood-brain and CSF barriers to penicillin and related organic acids.

Authors:  R A Fishman
Journal:  Arch Neurol       Date:  1966-08
  9 in total
  6 in total

Review 1.  Pharmacokinetics of the penicillins in man.

Authors:  M Barza; L Weinstein
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Influence of probenecid on serum and subcutaneous tissue fluid concentrations of benzylpenicillin and ceftazidime in human volunteers.

Authors:  B Hoffstedt; S Haidl; M Walder
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

Review 3.  Clinical pharmacokinetics of aztreonam.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 4.  The aminopenicillins: development and comparative properties.

Authors:  D S Reeves; D W Bullock
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.

Authors:  P H Vlasses; A M Holbrook; J J Schrogie; J D Rogers; R K Ferguson; W B Abrams
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

6.  Probenecid: an unexplained effect on cephalosporin pharmacology.

Authors:  P G Welling; S Dean; A Selen; M J Kendall; R Wise
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.